{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:50:28Z","timestamp":1767174628310,"version":"build-2238731810"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Omicron (B.1.1.529) is the fifth variant of concern of SARS-CoV-2, which has several subvariants. Clinical features of BA.1 and BA.2 infections have been described in the literature, but we have limited information about the clinical profile of BA.5, which caused the seventh wave in Iran.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective observational study was conducted on the BA.5 confirmed patients referred to Imam Khomeini Hospital Complex, Tehran, Iran, from 11th to 31st August 2022. The patients were divided into the two groups of outpatients and hospitalized patients, and their clinical, radiological, and laboratory data and outcomes were recorded and analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 193 patients with confirmed BA.5 infection, of whom 48 patients (24\u00b78%) were hospitalized. The mean age of the patients was 45\u00b73\u2009\u00b1\u200916\u00b75 years, and 113 patients (58\u00b75%) were female. The mean number of days patients had symptoms was 6\u00b78\u2009\u00b1\u20092\u00b74 days. The most common symptoms were weakness (69\u00b79%), sore throat (67\u00b74%), myalgia (66\u00b73%), hoarseness (63\u00b77%), headache (55\u00b74%), fatigue (54\u00b79%), and dry cough (50\u00b73%). Fever and dyspnea were significantly more observed in the hospitalized patients (p\u2009&lt;\u20090\u00b70001). The COVID-19 vaccination rate was significantly lower in hospitalized patients than in outpatients (35\/48\u201372\u00b79% vs. 140\/145\u2009\u2212\u200996\u00b76%, p\u2009&lt;\u20090\u00b70001). The most common underlying diseases were hypertension (16\u00b71%), diabetes mellitus (9\u00b78%), and cardiovascular diseases (9\u00b78%), all of which were significantly more common in hospitalized patients. Lung opacities were observed in 81\u00b72% of hospitalized patients. By the end of our study, 1\u00b75% of patients died despite receiving critical care services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggested that BA.5 symptoms are more non-respiratory and usually improve within 7 days. Although the proportion of hospitalized patients is still significant, very few patients require intensive care. COVID-19 vaccination is effective in reducing the hospitalization rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Not applicable. This study is not a clinical trial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08181-4","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T07:08:14Z","timestamp":1681715294000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characteristics and outcomes of COVID-19 patients during the BA.5 omicron wave in Tehran, Iran: a prospective observational study"],"prefix":"10.1186","volume":"23","author":[{"given":"Mohammadreza","family":"Salehi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezoo","family":"Salami Khaneshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas Shakoori","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Doomanlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Arabzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolfazl","family":"Sobati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousha","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Fattahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmaeil","family":"Mohammadnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asghar","family":"Abdoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayran","family":"Zebardast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"issue":"10317","key":"8181_CR1","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","volume":"398","author":"SSA Karim","year":"2021","unstructured":"Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021;398(10317):2126\u20138.","journal-title":"Lancet"},{"key":"8181_CR2","unstructured":"Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. 2022;603(7902):679\u201386."},{"issue":"7","key":"8181_CR3","doi-asserted-by":"publisher","first-page":"e961","DOI":"10.1016\/S2214-109X(22)00114-0","volume":"10","author":"W Jassat","year":"2022","unstructured":"Jassat W, Abdool Karim SS, Mudara C, Welch R, Ozougwu L, Groome MJ, et al. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study. The Lancet Global Health. 2022;10(7):e961\u2013e9.","journal-title":"The Lancet Global Health"},{"key":"8181_CR4","doi-asserted-by":"crossref","unstructured":"Jassat W, Karim S, Mudara C, Welch R, Ozougwu L, Groome M. Clinical severity of COVID-19 patients admitted to hospitals in Gauteng, South Africa during the Omicron-Dominant fourth wave. SSRN[Preprint]. 2021.","DOI":"10.2139\/ssrn.3996320"},{"issue":"6","key":"8181_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/jama.2021.24868","volume":"327","author":"C Maslo","year":"2022","unstructured":"Maslo C, Friedland R, Toubkin M, Laubscher A, Akaloo T, Kama B. Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron Wave compared with previous waves. JAMA. 2022;327(6):583\u20134.","journal-title":"JAMA"},{"issue":"10323","key":"8181_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","volume":"399","author":"N Wolter","year":"2022","unstructured":"Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. The Lancet. 2022;399(10323):437\u201346.","journal-title":"The Lancet"},{"issue":"7","key":"8181_CR7","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1056\/NEJMp2119682","volume":"386","author":"RP Bhattacharyya","year":"2022","unstructured":"Bhattacharyya RP, Hanage WP. Challenges in inferring intrinsic severity of the SARS-CoV-2 Omicron variant. N Engl J Med. 2022;386(7):e14.","journal-title":"N Engl J Med"},{"key":"8181_CR8","unstructured":"Brown J, Zhou J, Peacock TP, Barclay WS. The SARS-CoV-2 Variant, Omicron, Shows Enhanced Replication in Human Primary Nasal Epithelial Cells. BioRxiv. 2022."},{"key":"8181_CR9","doi-asserted-by":"crossref","unstructured":"Davies MA, Kassanjee R, Rosseau P, Morden E, Johnson L, Solomon W et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. medRxiv. 2022.","DOI":"10.1101\/2022.01.12.22269148"},{"key":"8181_CR10","doi-asserted-by":"crossref","unstructured":"Mahase E. Covid-19: What we know about the BA. 4 and BA. 5 omicron variants.bmj. 2022;378.","DOI":"10.1136\/bmj.o1969"},{"key":"8181_CR11","doi-asserted-by":"crossref","unstructured":"Mahase E. Covid-19: What do we know about omicron sublineages? bmj. 2022;376.","DOI":"10.1136\/bmj.o358"},{"key":"8181_CR12","doi-asserted-by":"crossref","unstructured":"Lewnard JA, Hong VX, Patel MM, Kahn R, Lipsitch M, Tartof SY. Clinical outcomes associated with SARS-CoV-2 Omicron (B. 1.1. 529) variant and BA. 1\/BA. 1.1 or BA. 2 subvariant infection in southern California. Nature Medicine. 2022:1-.","DOI":"10.1101\/2022.01.11.22269045"},{"key":"8181_CR13","unstructured":"Poonia G. Omicron variants BA.4 and BA. 5 cause surge in deaths and cases in Portugal: Desert News; 2022 [Available from: https:\/\/www.deseret.com\/coronavirus\/2022\/6\/3\/23153378\/new-omicron-variants-ba-4-ba-5-surge-cases-death-in-europe-portugal-south-africa."},{"key":"8181_CR14","doi-asserted-by":"crossref","unstructured":"Tegally H, Moir M, Everatt J, Giovanetti M, Scheepers C, Wilkinson E et al. Continued emergence and evolution of Omicron in South Africa: New BA. 4 and BA. 5 lineages. medRxiv. 2022.","DOI":"10.1101\/2022.05.01.22274406"},{"key":"8181_CR15","doi-asserted-by":"crossref","unstructured":"Wise J. Covid-19: Omicron sub variants driving new wave of infections in UK. bmj. 2022;377(1506).","DOI":"10.1136\/bmj.o1506"},{"issue":"51\u201352","key":"8181_CR16","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.15585\/mmwr.mm705152e3","volume":"70","author":"L Jansen","year":"2021","unstructured":"Jansen L, Tegomoh B, Lange K, Showalter K, Figliomeni J, Abdalhamid B, et al. Investigation of a SARS-CoV-2 B. 1.1. 529 (omicron) variant cluster\u2014Nebraska, November\u2013December 2021. Morb Mortal Wkly Rep. 2021;70(51\u201352):1782.","journal-title":"Morb Mortal Wkly Rep"},{"key":"8181_CR17","doi-asserted-by":"publisher","first-page":"175346662211103","DOI":"10.1177\/17534666221110346","volume":"16","author":"B Gu","year":"2022","unstructured":"Gu B, Yao L, Zhu X-y, Zou T, Feng Y-j, Yan J-y, et al. Comparison of initial clinic characteristics of hospitalized patients in Suzhou City during the COVID-19 Omicron wave with ancestral variant wave. Ther Adv Respir Dis. 2022;16:17534666221110346.","journal-title":"Ther Adv Respir Dis"},{"key":"8181_CR18","doi-asserted-by":"publisher","first-page":"106754","DOI":"10.1016\/j.ijsu.2022.106754","volume":"104","author":"S Sahebi","year":"2022","unstructured":"Sahebi S, Keikha M. Clinical features of SARS-CoV-2 Omicron BA. 2; Lessons from previous observations\u2013correspondence. Int J Surg (London England). 2022;104:106754.","journal-title":"Int J Surg (London England)"},{"key":"8181_CR19","doi-asserted-by":"crossref","unstructured":"Allameh SF, Nemati S, Ghalehtaki R, Mohammadnejad E, Aghili SM, Khajavirad N et al. Clinical characteristics and outcomes of 905 COVID-19 patients admitted to Imam Khomeini hospital complex in the capital city of Tehran, Iran.Arch Iran Med. 2020:766\u201375.","DOI":"10.34172\/aim.2020.102"},{"key":"8181_CR20","doi-asserted-by":"crossref","unstructured":"Chen X, Zheng F, Qing Y, Ding S, Yang D, Lei C et al. Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study. MedRxiv. 2020.","DOI":"10.1101\/2020.03.03.20030353"},{"issue":"10335","key":"8181_CR21","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","volume":"399","author":"C Menni","year":"2022","unstructured":"Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. The Lancet. 2022;399(10335):1618\u201324.","journal-title":"The Lancet"},{"issue":"10223","key":"8181_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497\u2013506.","journal-title":"The lancet"},{"issue":"11","key":"8181_CR23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061\u20139.","journal-title":"JAMA"},{"key":"8181_CR24","doi-asserted-by":"publisher","first-page":"104357","DOI":"10.1016\/j.jcv.2020.104357","volume":"127","author":"JA Siordia Jr","year":"2020","unstructured":"Siordia JA Jr. Epidemiology and clinical features of COVID-19: a review of current literature. J Clin Virol. 2020;127:104357.","journal-title":"J Clin Virol"},{"key":"8181_CR25","doi-asserted-by":"crossref","unstructured":"Wang L, Gao Y-h, Zhang LL-L. G-J. The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China. European Respiratory Journal. 2020;55(4).","DOI":"10.1183\/13993003.00398-2020"},{"key":"8181_CR26","doi-asserted-by":"crossref","unstructured":"Wise J. Covid-19: Symptomatic infection with omicron variant is milder and shorter than with delta, study reports. BMJ: British Medical Journal (Online). 2022;377.","DOI":"10.1136\/bmj.o922"},{"key":"8181_CR27","doi-asserted-by":"crossref","unstructured":"Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x et al. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2020.","DOI":"10.1056\/NEJMoa2002032"},{"key":"8181_CR28","doi-asserted-by":"crossref","unstructured":"Ma C, Gu J, Hou P, Zhang L, Bai Y, Guo Z, et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. medRxiv; 2020.","DOI":"10.1101\/2020.03.17.20037572"},{"issue":"5","key":"8181_CR29","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846\u20138.","journal-title":"Intensive Care Med"},{"key":"8181_CR30","unstructured":"Bager P, Wohlfahrt J, Bhatt S, Stegger M, Legarth R, M\u00f8ller CH, et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study. The Lancet Infectious Diseases; 2022."},{"issue":"10332","key":"8181_CR31","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","volume":"399","author":"T Nyberg","year":"2022","unstructured":"Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study. The Lancet. 2022;399(10332):1303\u201312.","journal-title":"The Lancet"},{"issue":"19","key":"8181_CR32","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMc2100362","volume":"384","author":"SS Abdool Karim","year":"2021","unstructured":"Abdool Karim SS, de Oliveira T. New SARS-CoV-2 variants\u2014clinical, public health, and vaccine implications. N Engl J Med. 2021;384(19):1866\u20138.","journal-title":"N Engl J Med"},{"issue":"5","key":"8181_CR33","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMc2119270","volume":"386","author":"S Collie","year":"2022","unstructured":"Collie S, Champion J, Moultrie H, Bekker L-G, Gray G. Effectiveness of BNT162b2 vaccine against omicron variant in South Africa. N Engl J Med. 2022;386(5):494\u20136.","journal-title":"N Engl J Med"},{"issue":"2","key":"8181_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1056\/NEJMoa2116063","volume":"386","author":"ES Rosenberg","year":"2021","unstructured":"Rosenberg ES, Dorabawila V, Easton D, Bauer UE, Kumar J, Hoen R, et al. Covid-19 vaccine effectiveness in New York State. N Engl J Med. 2021;386(2):116\u201327.","journal-title":"N Engl J Med"},{"issue":"6529","key":"8181_CR35","doi-asserted-by":"publisher","first-page":"eabf4063","DOI":"10.1126\/science.abf4063","volume":"371","author":"JM Dan","year":"2021","unstructured":"Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371(6529):eabf4063.","journal-title":"Science"},{"issue":"1","key":"8181_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-020-00362-2","volume":"19","author":"W Chen","year":"2020","unstructured":"Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob. 2020;19(1):1\u20137.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"8181_CR37","first-page":"46","volume":"20","author":"T Ghazanfari","year":"2021","unstructured":"Ghazanfari T, Salehi MR, Namaki S, Arabkheradmand J, Rostamian A, Rajabnia Chenary M, et al. Interpretation of hematological, biochemical, and immunological findings of COVID-19 Disease: biomarkers Associated with Severity and Mortality. Iran J Allergy Asthma Immunol. 2021;20(1):46\u201366.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"8181_CR38","doi-asserted-by":"publisher","first-page":"e13762","DOI":"10.7717\/peerj.13762","volume":"10","author":"K Suzuki","year":"2022","unstructured":"Suzuki K, Ichikawa T, Suzuki S, Tanino Y, Kakinoki Y. Clinical characteristics of the severe acute respiratory syndrome coronavirus 2 omicron variant compared with the delta variant: a retrospective case-control study of 318 outpatients from a single sight institute in Japan. PeerJ. 2022;10:e13762.","journal-title":"PeerJ"},{"key":"8181_CR39","doi-asserted-by":"crossref","unstructured":"Bi X, Zhang Y, Pan J, Chen C, Zheng Y, Wang J et al. Differences Between Omicron Infections and Fever Outpatients: Comparison of Clinical Manifestations and Initial Routine Hematology Indicators. Infection and Drug Resistance. 2022:5111\u201320.","DOI":"10.2147\/IDR.S378990"},{"key":"8181_CR40","doi-asserted-by":"crossref","unstructured":"Tsakok MT, Watson RA, Saujani SJ, Kong M, Xie C, Peschl H et al. Chest CT and Hospital Outcomes in Patients with Omicron Compared with Delta Variant SARS-CoV-2 Infection. Radiology. 2022:220533.","DOI":"10.1148\/radiol.220533"},{"issue":"7","key":"8181_CR41","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S1473-3099(20)30195-X","volume":"20","author":"D Baud","year":"2020","unstructured":"Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;20(7):773.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"8181_CR42","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.dsx.2020.06.067","volume":"14","author":"VK Jain","year":"2020","unstructured":"Jain VK, Iyengar K, Vaish A, Vaishya R. Differential mortality in COVID-19 patients from India and western countries. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(5):1037\u201341.","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"}],"updated-by":[{"DOI":"10.1186\/s12879-023-08507-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000}}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08181-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08181-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08181-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T17:08:48Z","timestamp":1700500128000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08181-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8181"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08181-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"18 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12879-023-08507-2","URL":"https:\/\/doi.org\/10.1186\/s12879-023-08507-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Tehran University of Medical Sciences, Tehran, Iran (No: IR.TUMS.MEDICINE.REC.1401.554). All methods were carried out in accordance with relevant guidelines and regulations. This study was conducted in an academic teaching\/research hospital (Imam Khomeini Hospital Complex affiliated to Tehran University of Medical Sciences). In this academic center, all patients or their legal guardians are initially explained that their information and possible samples will be anonymously collected and reviewed and reported in educational and research projects. The patients who give written consent to this issue will be included in the mentioned studies (like our study). Patients are allowed to freely choose whether or not their data be used in an anonymized database. This is also stated in the ethics committee approval. Informed consent was obtained from all the patients and\/or their legal guardian(s) for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}